Jones Financial Companies
PYXS icon

Jones Financial Companies’s Pyxis Oncology PYXS Stock Holding History

Jones Financial Companies’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$655 Hold
500
– – ﹤0.01% 4451
2025
Q4 		$575 Hold
500
– – ﹤0.01% 4135
2025
Q3 		$1.07K Sell
500
-1,000
-67% -$1.44K ﹤0.01% 3872
2025
Q2 		$1.65K Hold
1,500
– – ﹤0.01% 3531
2025
Q1 		$1.59K Hold
1,500
– – ﹤0.01% 3301
2024
Q4 		$2.34K Buy
1,500
+1,000
+200% +$2.88K ﹤0.01% 2958
2024
Q3 		$1.81K Hold
500
– – ﹤0.01% 2693
2024
Q2 		$1.66K Buy
+500
New +$2.1K ﹤0.01% 2201

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jones Financial Companies's PYXS Position: Q1 2026 in Review

Jones Financial Companies held its Pyxis Oncology (PYXS) position steady in Q1 2026 at 500 shares worth $655. The position accounts for ﹤0.01% of the portfolio, ranked #4451.

Jones Financial Companies first reported a position in PYXS in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.34K in Q4 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Jones Financial Companies held 500 shares of Pyxis Oncology worth $655 as of Q1 2026.
  • Jones Financial Companies left its Pyxis Oncology share count unchanged in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4451 holding.
  • Jones Financial Companies first reported a position in Pyxis Oncology in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Pyxis Oncology position peaked at $2.34K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.